Jared T. Hinkle

Johns Hopkins University — United States

Medicine · Health Sciences

16h-index1.5kcitations43works13.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(31), Neurological disorders and treatments(26), Genetic Neurodegenerative Diseases(6), Botulinum Toxin and Related Neurological Disorders(5), Neuroinflammation and Neurodegeneration Mechanisms(4)

Publications43 total

Psychedelic medicine: mechanisms, evidence, and translation to practice
BMJ·2026Open Access
Microglial Lag3 Drives α-Synuclein–induced Neurotoxic Activated (A1) Astrocytes and Neurodegeneration
2026Open Access
Commentary: A framework for assessment of adverse events in psychedelic research
Journal of Psychopharmacology·2024· 1 cited
Structural MRI Correlates of Anosognosia in Huntington’s Disease
Journal of Huntington s Disease·2024· 1 cited
Adverse Events in Studies of Classic Psychedelics
JAMA Psychiatry·2024· 82 citedOpen Access
Impact of Acute Dopamine Replacement on Cognitive Function in Parkinson's Disease
Movement Disorders Clinical Practice·2024· 10 citedOpen Access
Real or imagined: We need a new scale for psychosis in Parkinson's disease
Parkinsonism & Related Disorders·2024· 5 cited
The Association of Antidepressant Use and Impulse Control Disorder in Parkinson's Disease
American Journal of Geriatric Psychiatry·2024· 9 citedOpen Access
Examining the link between impulse control disorder and antidepressant use in Parkinson's disease
Parkinsonism & Related Disorders·2023· 6 citedOpen Access
Anxiety Change After Dopamine Therapy in Parkinson Disease is Independent of Motor Improvement
American Journal of Geriatric Psychiatry·2023· 8 citedOpen Access
Reconceptualizing Catatonia as “Psychiatric Parkinsonism”
American Journal of Geriatric Psychiatry·2023· 5 cited
Invited Perspective on “BPSD Patterns in Patients With Severe Neuropsychiatric Disturbances: Insight From the RECAGE Study” (Cognat et al. 2023)
American Journal of Geriatric Psychiatry·2023· 1 cited
Association of caregiver strain with the trajectory of quality of life in Parkinson's disease
Parkinsonism & Related Disorders·2023· 15 citedOpen Access
Longitudinal imaging highlights preferential basal ganglia circuit atrophy in Huntington’s disease
Brain Communications·2023· 19 citedOpen Access
The impact of caregiving on quality of life in Parkinson's disease: A systematic review
International Journal of Geriatric Psychiatry·2023· 11 citedOpen Access
‘Anxious fluctuators’ a subgroup of Parkinson's disease with high anxiety and problematic on-off fluctuations
Parkinsonism & Related Disorders·2022· 31 citedOpen Access
Management of Psychiatric Phenomena in Lewy Body Dementia
Psychiatric Annals·2022
Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson’s disease
Neuron·2022· 183 citedOpen Access
STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy
Proceedings of the National Academy of Sciences·2022· 204 citedOpen Access
Invited Perspective on “Apathy as a Within-Person Mediator of Depressive Symptoms and Cognition in Parkinson's Disease: Longitudinal Mediation Analyses”
American Journal of Geriatric Psychiatry·2021· 1 cited
page 1 of 3Next →

Frequent Co-authors

Gregory M. Pontone(31), Kelly A. Mills(19), Kate Perepezko(17), Ted M. Dawson(11), Zoltán Mari(10), Valina L. Dawson(6), Olga Pletniková(6), Juan C. Troncoso(6), Ankur Butala(6), Alexander Pantelyat(6), Liana S. Rosenthal(6), Melissa D. Shepard(5), Nicole Fischer(4), Joseph J. Gallo(4), Catherine C. Bakker(4), Tae‐In Kam(3), Nikhil Panicker(3), Senthilkumar S. Karuppagounder(3), Xiaobo Mao(3), Martinus P G Broen(3)